Angiotensin‐converting enzyme inhibitors vs ACEi plus angiotensin receptor blockers
Cardiovascular mortality · people with diabetes and kidney disease
Angiotensin‐converting‐enzyme inhibitors (ACEi) alone showed no clear difference in cardiovascular death Median compared with ACEi plus angiotensin receptor blockers (low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 3.02 [0.61, 14.85]4 studies · 994 participantsLow